14 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM PatientsBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 32026-09-30NCT06918002
A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to RituximabCryoglobulinemic vasculitisRecruitingPhase 22026-08-31NCT07268521
ENCOrafenib With Binimetinib in bRAF NSCLCNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-08-11NCT04526782
EWALL-PH OBSERVARTORY 2022Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingNot stated2026-07-06NCT07684131
Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane PemphigoidSevere Forms of Mucous Membrane PemphigoidActive, not recruitingPhase 32026-06-10NCT03295383
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingNot stated2026-04-13NCT05208086
Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status EpilepticusNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Status Epilepticus, nervous system disorder, visual epilepsyNot yet recruitingPhase 32026-02-10NCT07383779
Impact on Mortality of Hospitalisation of a Patient in a Hospital Bed That Does Not Correspond to His Needs After a Visit to the Emergency DepartmentEmergency Department PatientNot yet recruitingNot stated2026-01-21NCT07347847
Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?Disease Attributes, Emergencies, Pathologic Processes, Pathological Conditions, Signs and SymptomsRecruitingNot stated2026-01-05NCT03687528
Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Roomcardiovascular disorder, hypotensive disorder, vascular disorderRecruitingPhase 32025-12-02NCT06733129
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & ChemotherapyNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22025-11-18NCT05781308
Initial Standardized Global Review in Axial SpondyloarthritisAxial Spondylarthritis (axSpA)RecruitingNot applicable2025-08-26NCT07141017
Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and CaregiversNeurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and SymptomsRecruitingNot stated2025-05-31NCT06332495
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)Bacterial Infections and Mycoses, Infections, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, autoimmune disease, bacterial infectious disease, bone disorder, connective tissue disorder, gram-positive bacterial infections, immune system disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatic fever, rheumatoid arthritis, skin disorder, spondylitis, spondyloarthropathy, streptococcal infection, vertebral column disorderActive, not recruitingNot stated2025-01-23NCT04602091